Quest Diagnostics Inc

DGX: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|sZLOCK|VY&vLOCK|KDxjj?

Quest Diagnostics Earnings: M&A in 2024 Sets Stage for Strong 2025

Quest Diagnostics wrapped up 2024 with fourth-quarter results that featured both revenue and earnings growth of 15% year over year, reflecting the impact of key acquisitions made in 2024, including the addition of LifeLabs in Canada.

Sponsor Center